Sergej M Ostojic1, Marko Stojanovic, Patrik Drid, Jay R Hoffman. 1. Exercise Physiology Laboratory, Center for Health, Exercise and Sport Sciences, Stari DIF, Deligradska 27, 11000, Belgrade, Serbia, sergej.ostojic@chess.edu.rs.
Abstract
PURPOSE:Guanidinoacetic acid (GAA) is an intermediate in the biosynthesis of creatine (Cr), yet its use in human nutrition is limited due to a lack of a clear understanding of its' dose-response effect. Thus, the purpose of this study was to investigate the effect of three different dosages of GAA (1.2, 2.4 and 4.8 g/day) administered for 6 weeks on serum and urinary variables related to GAA metabolism. METHODS:Forty-eight healthy volunteers participated in the randomized, placebo-controlled, double-blind, repeated-measure study. At baseline, after 1, 2, 4 and 6 weeks, participants provided both fasting blood samples and 24-h urine. RESULTS:GAA intervention significantly increased serum and urinary GAA, Cr and creatinine as compared to placebo (P < 0.05). Differences were found for serum GAA andCr responses between the three GAA dosages, with high-dose GAA resulting in a greater increase (P < 0.05) in the plasma concentration of both variables as compared to other GAA dosages. In GAA groups, fasting plasma total homocysteine (T-Hcy) increased by 3.5 μmol/L on average at post-administration, yet no dose-response differences were found between trials. Serum B vitamins were not affected by either placebo or GAA intervention (P > 0.05). CONCLUSION: Results indicate that low-to-high dosages of exogenous GAA can increase serum concentrations of Cr and T-Hcy while not depleting the B vitamins pool available for remethylation of homocysteine. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, identification number NCT01133899.
RCT Entities:
PURPOSE:Guanidinoacetic acid (GAA) is an intermediate in the biosynthesis of creatine (Cr), yet its use in human nutrition is limited due to a lack of a clear understanding of its' dose-response effect. Thus, the purpose of this study was to investigate the effect of three different dosages of GAA (1.2, 2.4 and 4.8 g/day) administered for 6 weeks on serum and urinary variables related to GAA metabolism. METHODS: Forty-eight healthy volunteers participated in the randomized, placebo-controlled, double-blind, repeated-measure study. At baseline, after 1, 2, 4 and 6 weeks, participants provided both fasting blood samples and 24-h urine. RESULTS:GAA intervention significantly increased serum and urinary GAA, Cr and creatinine as compared to placebo (P < 0.05). Differences were found for serum GAA and Cr responses between the three GAA dosages, with high-dose GAA resulting in a greater increase (P < 0.05) in the plasma concentration of both variables as compared to other GAA dosages. In GAA groups, fasting plasma total homocysteine (T-Hcy) increased by 3.5 μmol/L on average at post-administration, yet no dose-response differences were found between trials. Serum B vitamins were not affected by either placebo or GAA intervention (P > 0.05). CONCLUSION: Results indicate that low-to-high dosages of exogenous GAA can increase serum concentrations of Cr and T-Hcy while not depleting the B vitamins pool available for remethylation of homocysteine. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, identification number NCT01133899.
Authors: Eiman Jahangir; Joseph A Vita; Diane Handy; Monica Holbrook; Joseph Palmisano; Ryan Beal; Joseph Loscalzo; Robert T Eberhardt Journal: Vasc Med Date: 2009-08 Impact factor: 3.239
Authors: Laura E McBreairty; Jason L Robinson; Kayla R Furlong; Janet A Brunton; Robert F Bertolo Journal: PLoS One Date: 2015-06-25 Impact factor: 3.240
Authors: Mehrnaz Ardalan; Matt D Miesner; Christopher D Reinhardt; Daniel U Thomson; Cheryl K Armendariz; J Scott Smith; Evan C Titgemeyer Journal: J Anim Sci Date: 2021-06-01 Impact factor: 3.338